Pathology - Research and Practice, Год журнала: 2024, Номер 257, С. 155294 - 155294
Опубликована: Апрель 5, 2024
Язык: Английский
Pathology - Research and Practice, Год журнала: 2024, Номер 257, С. 155294 - 155294
Опубликована: Апрель 5, 2024
Язык: Английский
Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 154991 - 154991
Опубликована: Ноя. 30, 2023
Язык: Английский
Процитировано
56Chemico-Biological Interactions, Год журнала: 2023, Номер 371, С. 110334 - 110334
Опубликована: Янв. 5, 2023
Язык: Английский
Процитировано
30Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 155015 - 155015
Опубликована: Дек. 6, 2023
Язык: Английский
Процитировано
25Clinica Chimica Acta, Год журнала: 2024, Номер 565, С. 119983 - 119983
Опубликована: Окт. 3, 2024
Язык: Английский
Процитировано
15Pathology - Research and Practice, Год журнала: 2024, Номер 256, С. 155259 - 155259
Опубликована: Март 11, 2024
Язык: Английский
Процитировано
12Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 155019 - 155019
Опубликована: Дек. 7, 2023
Язык: Английский
Процитировано
19Frontiers in Oncology, Год журнала: 2024, Номер 13
Опубликована: Янв. 18, 2024
In spite of the advances in immunotherapy and targeted therapies, lung cancer continues to be leading cause cancer-related death. The epidermal growth factor receptor is an established target for non-small cell (NSCLC), its overactivation by ligands can induce accelerated proliferation, angiogenesis, metastasis as well proinflammatory or immunosuppressive signals. CIMAvax-EGF (EGF)-depleting that approved treatment NSCLC patients Cuba. study was designed a phase IV trial characterize safety effectiveness advanced treated 119 community polyclinics 24 hospitals. consisted four bi-weekly doses followed monthly boosters. Overall, 741 ineligible further cancer-specific were enrolled. safe, most common adverse events mild-to-moderate injection site reactions, fever, chills, tremors, headache. For completing loading doses, median survival 9.9 months. individuals achieving at least stable disease frontline vaccination induction, 12 Most functional activities symptoms evaluated through European Organisation Research Treatment Cancer (EORTC) QLQ-C30 questionnaire improved over time. conclusion, this real-world demonstrated safe effective who vaccinated maintenance scenario. A larger effect seen subjects with poor prognosis like those squamous tumors high EGF levels. Remarkably, community-based intervention very important because it feasibility treating active primary care institutions. addition CIMAvax-EGF, received supportive clinic. Vaccine administration family doctors reduced patients’ burden on medical oncology services continued providing chemotherapy other complex therapies. We conclude constitute optimal scenario administering vaccines are require prolonged cancer, despite continuous deterioration their general condition. Clinical registration https://rpcec.sld.cu/trials/RPCEC00000205-En , identifier RPCEC00000205.
Язык: Английский
Процитировано
7Pathology - Research and Practice, Год журнала: 2024, Номер 257, С. 155282 - 155282
Опубликована: Апрель 1, 2024
Язык: Английский
Процитировано
7PubMed, Год журнала: 2024, Номер 23, С. 570 - 599
Опубликована: Янв. 1, 2024
Cancer poses intricate challenges to treatment due its complexity and diversity. Ferroptosis circular RNAs (circRNAs) are emerging as innovative therapeutic avenues amid the evolving landscape of cancer therapy. Extensive investigations into circRNAs reveal their diverse roles, ranging from molecular regulators pivotal influencers ferroptosis in cell lines. The results underscore significance modulating pathways that impact crucial aspects development, including survival, proliferation, metastasis. A detailed analysis delineates these pathways, shedding light on mechanisms through which influence ferroptosis. Building upon recent experimental findings, study evaluates potential targeting induce By identifying specific associated with etiology cancer, this paves way for development targeted therapeutics exploit vulnerabilities cells. This review consolidates existing understanding circRNAs, emphasizing role therapy providing impetus ongoing research dynamic field. See also graphical abstract(Fig. 1).
Язык: Английский
Процитировано
7Bioorganic Chemistry, Год журнала: 2023, Номер 134, С. 106444 - 106444
Опубликована: Фев. 25, 2023
Язык: Английский
Процитировано
15